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Abstract: Gamithromycin and tulathromycin are commonly used in the treatment of bovine respiratory bacterial diseases. The current
work was undertaken to establish the apoptotic, necrotic, and cytotoxic effects of these antibiotics in the target animal. Cells with
apoptosis and necrosis were determined by dual staining method, cytotoxic effects were determined by MTT assay, cell proliferative
effects were examined by XCelligence real-time cell analysis system (RTCA-SP). The comparison between gamithromycin and
tulathromycin concentrations on tracheal cells in terms of % cell viability was found to be significantly different. While the cell viability
percentage of gamithromycin was higher at 150 µg/mL, 180 µg/mL, and 240 µg/mL than tulathromycin, and at 2 µg/mL, 4 µg/mL, 10
µg/mL, 20 µg/mL, and 50 µg/mL concentrations tulathromycin cell viability was higher than gamithromycin (p < 0.05). When the
staining method data were evaluated, the difference between the results of % apoptotic index at 20 µg/mL concentration was significant
and it was found that gamithromycin had more apoptotic effect than tulathromycin (p < 0.05). It was seen that tulathromycin and
gamithromycin applied on tracheal epithelial cells at concentrations of 2 and 10 µg/mL increased the viability depending on time. The
increase in epithelial cell proliferation of gamithromycin and tulathromycin due to time shows that these antibiotics can maintain longterm prophylactic treatment against diseases.
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1. Introduction
Macrolides have been widely used in skin, respiratory and
gastrointestinal systems and soft tissue infections since
the second half of the 20th century [1,2]. Since macrolides
are lipophilic weak basic drugs [3], they easily penetrate
tissues by passive diffusion [4].
The concentration of macrolides in peripheral tissues
is higher than serum concentrations, they have long halflives, wide distribution to tissues, and their concentration
in the lung are long-lasting, making them one of the
first antibiotics used in the treatment and prevention of
respiratory diseases [5–7]. New generation macrolides
such as gamithromycin and tulathromycin, which were
developed in recent years, are used in the treatment of
respiratory bacterial diseases of cow and pig [2, 8–11].
Macrolides have the ability to penetrate and accumulate
in many eukaryotic cell types. Though not as much as
neutrophils and macrophages, they can accumulate in
epithelial-like cell lines [12]. Airway epithelium is a
physicochemical barrier that plays a vital role in host
defence against inhaled pathogens (bacteria, virus, etc.)

and irritants [13,14]. When respiratory epithelial cells are
subject to inflammatory mediators, macrolide antibiotics
have a protective impact against epithelial injury [15].
Because of these properties, they show a therapeutic effect
against intracellular organisms [12].
Macrolide group antibiotics are known to regulate
the functions of immune system cells as well as their
antimicrobial effect. Studies conducted in recent years show
that some macrolide group antibiotics cause apoptosis
[16,17]. To our knowledge, there is no study conducted
on bovine tracheal epithelial cells cytotoxic, apoptotic,
necrotic, and proliferative effects of gamithromycin and
tulathromycin. The aim of this study was to investigate
cytotoxic, necrotic, apoptotic, and cell proliferative effects
of tulathromycin and gamithromycin on in vitro bovine
tracheal epithelial cells.
2. Materials and methods
2.1. Chemicals
Tulathromycin (Sigma-Aldrich SLM2107, Germany) and
gamithromycin (Sigma-Aldrich 32161, Germany) used
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in the experiments were dissolved in dimethyl sulfoxide
(DMSO, Isolab, Germany).
2.2. Bovine tracheal epithelial cell isolation and cell
culture
Tracheal epithelial tissue samples, from 12–36 months
old Simmental breed male cattle, slaughtered in a local
slaughterhouse, were transported to the cell culture
laboratory with a centrifuge tube (50 mL, Corning, USA)
containing a transport solution [99% DMEM, (Dulbecco’s
modified eagles medium), 1% penicillin-streptomycin,
Biological Industries, Israel]. To isolate epithelial cells,
samples were mechanically scraped with a sterile scalpel
from tracheal epithelial tissue and cut into very small pieces.
Then these samples were placed in 25 cm2 culture flasks
(Corning, USA) with 3 mL of cell medium [79% DMEM,
20% foetal bovine serum (Biological Industries, Israel), 1%
penicillin-streptomycin] was added and incubated in the
incubator (5% CO2, 37oC). The cell medium (89% DMEM,
10% foetal bovine serum, 1% penicillin-streptomycin) was
changed every 48 h due to the proliferation of tracheal
epithelial cells [18, 19].
2.3. Cytotoxicity assays
After counting bovine tracheal epithelial cells; 10 ×103
cells (100 µL) were seeded to each well in a 96-well plate
(Corning, USA). 2, 4, 10, 20, 50, 100, 120, 150, 180, 210,
240, 300 µg/mL of gamithromycin or tulathromycin
were applied on the cells with triplicates for each test
group. Doses were selected according to the treatment
and target concentration in the tissue. As the control
group; 0.5% DMSO medium mixture was added to the
cells. Cells were incubated again for 24 h. At the end of
the incubation, the cell media in 96-well plated was
discarded and 50 µL of 3-(4,5-Dimethyl-2-thiazolyl)-2,5diphenyl-2H-tetrazolium bromide (MTT, AmbrescoLife Science, USA) solution was added to the wells. Cells
were incubated in the incubator for 2 h. At the end of the
incubation, the cell media in 96-well plated was discarded,
100 µL of isopropanol (Sigma, Germany) was added and
it was analysed in plate reader (Biotek, USA) at 570 nm
wavelength. The cytotoxicity test method was carried out
in accordance with ISO 10993-5 protocol [20]. The MTT
assay was repeated three times.
2.4. Determination of apoptosis and necrosis by dual
staining method
Tracheal epithelial cells were seeded at 10 ×103 cells in a
48-well plate. 2, 4, 10, 20, 50, 100 µg/mL of gamithromycin
or tulathromycin were applied on the cells in triplicates for
each test group. As the control group; 0.5% DMSO medium
mixture was added to the cells. Cells were incubated again
for 24 h. At the end of incubation, cell media in 48-well
plated wells were discarded and 70 µL of double staining
solution (2 mg/mL hoechst 33342, 100 µg/mL ribonuclease
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A, 2 µg/mL propidium iodide, Serva, Israel) were added.
At the end of this 15-min incubation; apoptotic cells were
evaluated using the DAPI filter (340–488 nm wavelength)
and necrotic cells were evaluated using the FITC filter
(480–520 nm wavelength) by inverted microscope (Leica
DM6000B, Germany) [21]. The dual staining method was
repeated three times.
2.5. Determination of cell proliferation by real-time cell
analysis system
Gamithromycin or tulathromycin between 2 µg/mL and 10
µg/mL concentrations were applied on the cells seeded at 5
×103 cells per 96-well e-plate in triplicate. DMSO medium
mixture (0.5%) was added to the cells as control group;
20% DMSO medium mixture was added to the cells in the
positive control group. E-plate was placed in the RTCASP (Roche, Germany) and cultured for 96 h and real-time
impedance measurement was taken from the system every
10 min. After 96-h of incubation, graphs showing timedependent cell proliferation were obtained [21].
2.6. Statistical analysis
The data from the cytotoxicity, apoptosis and necrosis
assays were calculated using Microsoft Excel (Microsoft
Office 2010) program. GraphPad Prism (Software ver. 6)
was used to calculate IC50 (the half-maximal inhibitory
concentration) from the MTT assay. The data obtained
in the study were given as arithmetic mean ± standard
error. Statistical analyses were done by SPSS 15.0 package
program. Student t-test was performed to evaluate the
difference between gamithromycin and tulathromycin
groups. p < 0.05 value was accepted as significant.
3. Result
3.1. Cytotoxic effects of tulathromycin and
gamithromycin
Cytotoxicity results of tulathromycin and gamithromycin
applied on bovine tracheal epithelial cells are given in Figure
1 and Figure 2. While the viability of gamithromycin at the
highest concentration (300 μg/mL) was 25.701 ± 3.37%,
the viability of tulathromycin was 20.093 ± 2.47%. At a low
concentration (2 μg / mL), the viability of tulathromycin
(172.197 ± 3.23%) was higher than that of gamithromycin
(128.251 ± 11.45%). IC50 values of gamithromycin and
tulathromycin were calculated according to the results of
the MTT method, in bovine tracheal epithelial cells. IC50
value of gamithromycin was 156 ± 9 µg/mL and the IC50
value of tulathromycin was 134.7 ± 7.1 µg/mL. When the
same concentrations of gamithromycin and tulathromycin
are compared; statistical significance was found between
2 µg/mL, 4 µg/mL, 10 µg/mL, 20 µg/mL, 50 µg/mL, 150
µg/mL, 180 µg/mL, and 240 µg/mL concentrations in
terms of cell viability. While the cell viability percentage of
gamithromycin was higher at 150 µg/mL, 180 µg/mL, and
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Figure 1. The effect of tulathromycin and gamithromycin on the cell viability of
tracheal epithelial cells at concentrations between 2 µg/mL–100 µg/mL. *,The
difference between the groups is significant (p < 0.05).

Figure 2. The effect of tulathromycin and gamithromycin on the cell viability of
tracheal epithelial cells at concentrations between 120 µg/mL–300 µg/mL. *, The
difference between the groups is significant (p < 0.05).

240 µg/mL than those of tulathromycin; at 2 µg/mL, 4 µg/
mL, 10 µg/mL, 20 µg/mL, and 50 µg/mL concentrations
tulathromycin cell viability was higher than gamithromycin
(p < 0.05) (Figure 1, Figure 2).
3.2. Cell apoptosis and necrosis of gamithromycin and
tulathromycin
The percentage (%) apoptotic and necrotic index
results of tracheal epithelial cells of tulathromycin and
gamithromycin are given in Figure 3 and Figure 4,
respectively. As the concentration of both antibiotics
increased, apoptotic and necrotic cell percentage (%)
index results were increased. However, at 20 µg/mL
concentration, the difference in apoptotic percentage (%)
index results between gamithromycin and tulathromycin
was significant and the percentage of apoptotic cells was
higher in gamithromycin than that of tulathromycin
(p < 0.05). According to the necrotic cell percentage
(%) index results, the difference between 20 and 100

µg/mL concentrations was statistically significant and
it was found that the percentage of necrotic cells was
higher in gamithromycin than that of tulathromycin (p
< 0.05). Apoptotic and necrotic cell images of tracheal
epithelial cells in the control group and gamithromycin,
tulathromycin groups are shown in Figure 5.
3.3. Cell proliferation of gamithromycin and
tulathromycin
After plating the tracheal epithelial cells to E-plate the cell
proliferation graphics were obtained for approximately 96
h. Concentrations of gamithromycin and tulathromycin
(2 and 10 µg/mL) were administered at the 24th h. A
comparative proliferation graph of gamithromycin and
tulathromycin applied on tracheal epithelial cells at 2 µg/
mL is given in Figure 6. In the first 10 h following antibiotic
administration to tracheal epithelial cells, cell proliferation
was found to be higher in tulathromycin when compared
to gamithromycin. Gamithromycin was found to have
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Figure 3. Apoptotic cell percentage (%) index of tracheal epithelial cells at
concentrations between 2 µg/mL–100 µg/mL of tulathromycin and gamithromycin.
*, The difference between the groups is significant (p < 0.05).

1

Figure 4. Necrotic cell percentage (%) index of tracheal epithelial cells
at concentrations between 2 µg/mL–100 µg/mL of tulathromycin and
gamithromycin. *, The difference between the groups is significant (p < 0.05).

a higher cell proliferation rate than tulathromycin for
approximately 50 h after 10 h. In addition, after application
to tracheal epithelial cells, a continuous increase in
proliferation was observed in gamithromycin and
tulathromycin (2 µg/mL) while proliferation decreased
after a certain time in the control groups.
A comparative proliferation graph of gamithromycin
and tulathromycin applied on tracheal epithelial cells
at 10 µg/mL is given in Figure 7. The first 30 h after
gamithromycin and tulathromycin were applied to
tracheal epithelial cells; it was found that cell proliferation
was higher in tulathromycin than that of gamithromycin.
On the other hand, after 30 h, the cell proliferation rate was
higher in gamithromycin than tulathromycin. In addition,
while proliferation increased in tracheal epithelial cells for
approximately 54 h after gamithromycin and tulathromycin

142

application, a decrease in cell proliferation was observed
after 78 h. Tracheal epithelial cell proliferation in the
negative control group was increased in the first 52 h,
while a decrease was observed after the 52nd hour. Cell
proliferation in the positive control group; increased in the
first hours, then stopped and decreased at last.
4. Discussion and conclusions
Cell viability and/or proliferation rates are the best
parameters that give information about the health status
of the cells. Generally, the health and metabolism of cells
are affected by factors such as concentration of physical
or chemical substances, temperature, and application
time. If the chemical agents have different mechanisms
such as destroying the cell membrane, and irreversible
binding to receptors, toxicity occurs in the cells. Therefore,
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Figure 5. Apoptotic and necrotic cell image in the tracheal epithelial cells of gamithromycin, tulathromycin, and control group. CA:
Control group apoptotic cell image, CN: Control group necrotic cell image, G2A: Gamithromycin 2μg/mL, apoptotic cell image, G2N:
Gamithromycin 2μg/mL, necrotic cell image, G100A: Gamithromycin 100μg/mL, apoptotic cell image, G100N: Gamithromycin 100μg/
mL, necrotic cell image, T2A: Tulathromycin 2μg/mL, apoptotic cell image, T2N: Tulathromycin 2μg/mL, necrotic cell image, T100N:
Tulathromycin 100μg/mL, apoptotic cell image, T100N: Tulathromycin 100μg/mL, necrotic cell image, (photos were taken at 20X
magnification under Leica DM6000 Inverted Microscope).

1

Figure 6. Comparative proliferation graph of tracheal epithelial cells at a concentration of 2 µg/mL of gamithromycin
and tulathromycin.

cell viability or cytotoxicity assays provide an important
advantage in determining the cytotoxic effects of drugs
and chemicals [22].

Duewelhenke et al. [23] reported an increase in
the cytotoxic effect of the macrolide group antibiotic
azithromycin and roxithromycin on the primary human
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Figure 7. Comparative proliferation graph of tracheal epithelial cells at a concentration of 10 µg/mL of gamithromycin
and tulathromycin.

osteoblast cells depending on the concentration (100 µg/
mL 20%–30%, 200 µg/mL 30%–45%, 400 µg/ mL 40%–
60%).
Viluksela et al. [24] researched the cytotoxic effects
of macrolide antibiotics on liver cells. They declared
erythromycin estolate has the most cytotoxic effect on
liver cells after 4–48 h incubation, and this macrolide
is followed by erythromycin 11,12-cyclic carbonate,
clarithromycin, roxythromycin, erythromycin base,
azithromycin, respectively. The findings of the present
study are consistent with the findings of Duewelhenke et
al. and Viluksela et al. [23,24]. Thus this study also showed
that cytotoxicity of tulathromycin and gamithromycin
varies depending on the concentration of the substances
and time. When IC50 values are evaluated according to
MTT results, the IC50 value of gamithromycin (156 ±
9 µg/mL) is higher than the IC50 value (134.7 ± 7.1 µg/
mL) of tulathromycin. According to these values, it can
be concluded that gamithromycin has higher confidence
intervals in terms of cytotoxicity on tracheal epithelial cells
than tulathromycin.
Recent studies have reported that cytotoxicity caused
by some drugs is due to the cells’ mitochondrial toxicity.
With the increase of mitochondrial toxicity in cells
formed by drugs; organ toxicity may occur in the liver,
skeletal muscle, kidney, and heart. The drugs that cause
mitochondrial toxicity are cholesterol-lowering drugs,
antidiabetics, pain relievers (NSAIDs), some antibiotics
(fluoroquinolones, macrolides), and anticancer drugs
[25]. Jiang et al. [26] declared that due to the increased
concentration of azithromycin; the proliferation of
human fibroblast and MCF-12A cells is reduced and
caused mitochondrial toxicity. Although the cell lines are
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different, in accordance with the presented study, high
concentrations of both active substances cause a decrease
in cell viability. Therefore; toxicity on tracheal epithelial
cells induced by gamithromycin and tulathromycin is
thought to occur as a result of mitochondrial toxicity, as
induced by other macrolide group antibiotics.
Apoptosis plays a significant role in the development
and maintenance of all mammalian tissues. The damage
or aging is eliminated with programmed cell death
without harming the mammal by apoptosis [27]. Data
obtained from human and animal lung biopsies show that
apoptosis has a significant effect on the development of
cell proliferation and various respiratory diseases [28].
Macrolides have been shown to cause apoptosis on
macrophages and epithelial cells [17]. Duquette et al.
[29] reported that neutrophil and monocyte-derived
macrophages isolated from porcine blood samples induce
apoptosis depending on the concentration and duration
of exposure to tulathromycin. In another study, Moges
et al. [30] stated that the apoptosis induced by tylosin
(0.1, 1, and 10 µg/mL) on neutrophil and monocytederived macrophages from pig blood varies with time and
concentration. In the present study, apoptosis and necrosis
on the tracheal epithelial cells caused by gamithromycin
and tulathromycin were changed depending on the
concentration. Although the drugs and cell lines used in
the study are different, the results are compatible with
the results of Duquette et al. and Moges et al. [29, 30]
studies showing an increase in the percentage of apoptosis
on tracheal epithelial cells due to an increase in the
concentration of the drugs.
Apoptosis is an important key for the regeneration
event. The proliferative aspect of the regeneration event,
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including blastema formation, is stimulated by signals
from apoptotic cells [31]. According to the results of the
real-time cell analysis system, apoptosis was observed in
tracheal epithelial cells and it is thought that proliferation
seen in the concentrations of both substances at 2 and 10
µg/mL may be caused by signals from apoptotic cells.
Real-time cell analysis system provides real-time
monitoring of changes in cell proliferation and toxicity of
tulathromycin (t1/2: about 73 h) and gamithromycin (t1/2:
about 60 h) [7,32]. According to the results of the cell
analysis system performed in the present study, epithelial
cell proliferation increased depending on the time in low
concentrations of gamithromycin and tulathromycin. It
is suggested that gamithromycin and tulathromycin may
have a therapeutic effect against epithelial damage that
may occur in tracheal epithelial cells like other macrolide
group antibiotics due to their cell proliferation enhancing
properties.
As a result; the effects of macrolide antibiotics
may differ depending on their chemical structure and
concentrations and the cell and animal species to which
they are applied. The cytotoxicity of gamithromycin (2

and 4 µg/mL) and tulathromycin (2, 4, and 10 µg/mL),
which has the ability to penetrate and accumulate into the
cell, is very low in tracheal epithelial cells and thus can
be used safely. Between these antibiotics, the confidence
interval is higher in gamithromycin. The apoptosis caused
by both antibiotics can increase the proliferation effects
of the cells and protect the cells against damage that may
occur in epithelial cells, where the disease agent was first
encountered. The results of the real-time cell analysis
system revealed that gamithromycin and tulathromycin
increased epithelial cell proliferation depending on the
time; which is beneficial besides its antimicrobial activity.
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